Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 22 studies | 24% ± 5% | |
ciliated cell | 14 studies | 28% ± 11% | |
endothelial cell | 13 studies | 24% ± 6% | |
smooth muscle cell | 10 studies | 20% ± 5% | |
macrophage | 10 studies | 28% ± 12% | |
endothelial cell of lymphatic vessel | 7 studies | 29% ± 9% | |
goblet cell | 7 studies | 28% ± 16% | |
retinal cone cell | 7 studies | 54% ± 18% | |
pericyte | 7 studies | 19% ± 4% | |
myeloid cell | 7 studies | 27% ± 4% | |
classical monocyte | 6 studies | 28% ± 10% | |
microglial cell | 6 studies | 31% ± 11% | |
epithelial cell | 6 studies | 46% ± 10% | |
dendritic cell | 6 studies | 24% ± 15% | |
intestinal crypt stem cell | 5 studies | 30% ± 11% | |
myofibroblast cell | 5 studies | 26% ± 5% | |
transit amplifying cell | 5 studies | 39% ± 17% | |
glutamatergic neuron | 5 studies | 29% ± 15% | |
precursor B cell | 5 studies | 31% ± 8% | |
pro-B cell | 5 studies | 41% ± 4% | |
B cell | 5 studies | 23% ± 4% | |
type I pneumocyte | 5 studies | 18% ± 2% | |
neuron | 4 studies | 25% ± 8% | |
monocyte | 4 studies | 26% ± 6% | |
lymphocyte | 4 studies | 21% ± 3% | |
club cell | 4 studies | 21% ± 5% | |
CD4-positive, alpha-beta T cell | 3 studies | 19% ± 3% | |
hematopoietic precursor cell | 3 studies | 28% ± 11% | |
plasma cell | 3 studies | 31% ± 6% | |
mononuclear phagocyte | 3 studies | 23% ± 4% | |
muscle cell | 3 studies | 33% ± 14% | |
type II pneumocyte | 3 studies | 17% ± 2% | |
enteroendocrine cell | 3 studies | 29% ± 5% | |
alveolar macrophage | 3 studies | 22% ± 6% | |
Schwann cell | 3 studies | 20% ± 4% | |
basal cell | 3 studies | 28% ± 16% | |
interneuron | 3 studies | 38% ± 20% | |
GABAergic neuron | 3 studies | 36% ± 14% | |
astrocyte | 3 studies | 29% ± 5% | |
oligodendrocyte | 3 studies | 26% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 100% | 25566.41 | 966 / 966 | 100% | 52.17 | 527 / 527 |
skin | 100% | 7509.18 | 1807 / 1809 | 100% | 38.89 | 472 / 472 |
thymus | 100% | 16630.34 | 653 / 653 | 100% | 32.63 | 603 / 605 |
stomach | 100% | 13438.92 | 359 / 359 | 100% | 50.34 | 285 / 286 |
esophagus | 100% | 12496.08 | 1439 / 1445 | 100% | 40.91 | 183 / 183 |
adrenal gland | 100% | 10512.39 | 258 / 258 | 99% | 29.52 | 228 / 230 |
uterus | 99% | 12696.42 | 169 / 170 | 100% | 25.52 | 457 / 459 |
pancreas | 100% | 13592.80 | 328 / 328 | 99% | 33.43 | 176 / 178 |
lung | 100% | 11630.82 | 577 / 578 | 99% | 30.03 | 1139 / 1155 |
prostate | 100% | 11055.87 | 244 / 245 | 99% | 23.57 | 495 / 502 |
ovary | 100% | 16843.46 | 180 / 180 | 98% | 23.92 | 421 / 430 |
bladder | 100% | 18461.14 | 21 / 21 | 98% | 27.83 | 492 / 504 |
breast | 100% | 8217.74 | 458 / 459 | 98% | 22.21 | 1091 / 1118 |
kidney | 100% | 7902.37 | 89 / 89 | 96% | 21.15 | 866 / 901 |
brain | 71% | 3103.36 | 1872 / 2642 | 98% | 17.30 | 692 / 705 |
liver | 92% | 6189.60 | 209 / 226 | 71% | 8.90 | 290 / 406 |
adipose | 100% | 9302.09 | 1204 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 30365.03 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 13668.18 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 20.65 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 10.74 | 1 / 1 |
blood vessel | 100% | 9915.70 | 1333 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 19.34 | 79 / 80 |
lymph node | 0% | 0 | 0 / 0 | 97% | 17.08 | 28 / 29 |
heart | 96% | 5558.60 | 829 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 83% | 7609.40 | 767 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0005741 | Cellular component | mitochondrial outer membrane |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0046983 | Molecular function | protein dimerization activity |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
Gene name | MLXIP |
Protein name | MLX-interacting protein (Class E basic helix-loop-helix protein 36) (bHLHe36) (Transcriptional activator MondoA) Alternative protein MLXIP MLX interacting protein |
Synonyms | MONDOA MIR KIAA0867 BHLHE36 |
Description | FUNCTION: Binds DNA as a heterodimer with MLX and activates transcription. Binds to the canonical E box sequence 5'-CACGTG-3'. Plays a role in transcriptional activation of glycolytic target genes. Involved in glucose-responsive gene regulation. . |
Accessions | L8EAR3 ENST00000319080.12 [Q9HAP2-1] ENST00000538698.5 [Q9HAP2-2] ENST00000625732.3 [Q9HAP2-1] ENST00000535430.5 F5H321 F5H0V4 ENST00000366272.6 H0YGR9 ENST00000542417.1 Q9HAP2 ENST00000629738.4 [Q9HAP2-1] |